Exciting News! Our Type 2 Diabetes clinical trial has successfully concluded! The study tested the safety and effectiveness of a non-drug, non-invasive neurostimulation wearable device designed to help adults with Type 2 Diabetes improve their blood sugar control. Thank you to all our dedicated participants and researchers who made this study possible. #Neurovalens #DiabetesResearch #InnovationInHealth #ClinicalTrialSuccess #Neurostimulation #Type2Diabetes
Neurovalens
Medical Equipment Manufacturing
We develop non-invasive neurostimulation products used to solve some of the world’s greatest health challenges
About us
Based in Belfast, Neurovalens is a global health-tech company that creates non-invasive neurostimulation products used to solve some of the world's greatest health challenges! Modius is the first product from Neurovalens which successfully launched in August 2017 on Indiegogo. Modius was designed to help improve the lives of people who struggle with their weight by using neuro-technology to help make weight loss easier. Awards: Winner: Health Category at the Future Planet Awards 2019 Winner: Best New Concept or Innovation at the 2018 Yahoo Sports Technology Awards Winner: 2018 CES Innovation Award Winner: Start-Up of the Year at the 2018 Digital DNA Awards Winner: Start-Up World Cup Northern Ireland Winner 2018 Winner: Randox Health Weight Management Product of the Year 2018 Winner: Business Eye Small Business Awards Healthcare Business of the Year 2018 Winner: Innovative Business of the Year at the BEFTA 2018 awards Placed 3rd at 2018 CES Last Gadget Standing Finalist for Med Tech Innovator Award Finalist in the Best Investment in the Disruptive Tech category at the UK Business Angel Investment Awards 2019
- Website
-
https://neurovalens.com/
External link for Neurovalens
- Industry
- Medical Equipment Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Belfast
- Type
- Privately Held
- Founded
- 2013
- Specialties
- Neurostimulation, Neuroendocrine, Hypothalamus, health, technology, Sleep, Stress, and Type 2 Diabetes
Locations
-
Primary
Belfast, GB
Employees at Neurovalens
-
Tina Liedtky
President, Transplant Diagnostics Division at Thermo Fisher Scientific
-
Kerry Baldwin
Managing Partner, Co-founder IQ Capital Deeptech VC, Past Chair British Private Equity and Venture Capital Association 2021/22
-
Kate Willis
MedTech Executive | Mentor | Speaker | Consultant | Board Member | Magic Maker
-
Chris McCabe
CTO at Neurovalens
Updates
-
Sleep makes up a quarter to a third of our lives, so quality sleep is essential for a better overall lifestyle. Struggling with sleep? Modius Sleep is a revolutionary, FDA-cleared device designed to treat Chronic Insomnia. Worn like headphones for just 30 minutes each evening, it offers a drug-free, non-invasive solution. Improve your sleep quality with Modius Sleep: https://ow.ly/bFJN50SIYAJ #ModiusSleep #BetterSleep #HealthTech #InsomniaTreatment
-
Neurovalens reposted this
🌟 Meet our Change Makers🌟 Have you spotted our new billboard ad campaign? We're thrilled to introduce Dr Jason McKeown, one of our esteemed partners featured in the campaign. As the CEO of Neurovalens, Dr Jason McKeown has chosen Ulster University as a key partner to advance health technology innovations. His groundbreaking work in developing non-invasive neurostimulation devices is transforming medical treatments and has the potential to improve the quality of life for countless people. Thanks to Ulster University's insomnia research and testing, Neurovalens achieved a significant milestone last November: U.S. FDA clearance for their 'Modius Sleep' device. This innovative device uses non-invasive electrical stimulation to target key areas of the brain and nervous system, offering a groundbreaking solution for chronic insomnia without the need for surgery or medication. This advancement not only supports those with sleep disorders but also alleviates pressure on our healthcare system. Discover more about our campaign and the inspiring stories behind it: https://ow.ly/G7kE50SO9BL #WeAreUU
-
Sleep deprivation has serious consequences, including mood changes like irritability, anxiety, lack of motivation, and even depression, according to the American Academy of Sleep Medicine (AASM). Don't let poor sleep affect your life. Discover how our FDA-cleared Modius Sleep device can help improve your sleep and mood. Learn more on our website: https://ow.ly/rzBq50SMVLX #BetterSleep #ModiusSleep #HealthTech #InsomniaTreatment
-
Neurostimulation has been a game-changer in treating chronic conditions for many years, offering improved quality of life, reduced dependence on medication, and a low-risk approach to treatment. With Modius Sleep, you can experience these benefits with a non-invasive option from the comfort of your own home. Discover more: https://ow.ly/zi7J50SIYFK #BetterSleep #ModiusSleep #HealthTech #InsomniaTreatment #neurostimulation
-
Today is your last chance to come and talk to us about Modius Sleep, an FDA cleared treatment for Chronic Insomnia at the 2024 NYC Neuromodulation Conference. FIND US: Main Exhibition Hall, Poster A84. Ulster University #modiussleep #nycn2024 #insomnia #medtech
-
Great to share the Modius Sleep device with Richard Bermudes, M.D. and many others at the 2024 NYC Neuromodulation Conference. Modius Sleep is a non-drug non-invasive treatment for Chronic Insomnia that achieved FDA clearance in October 2023. Visit us in the main exhibition hall (poster A84) to find out more and try it for yourself. #insomnia #modiussleep #neuromodulation #nycn2024
Physician Executive, Consultant in Innovative Psychiatric Treatments (Interventional Psychiatry), Health IT, BH Quality, and Practice Management. Fellow of the Clinical TMS Society and Academy of Cognitive Therapy.
Exciting news from Neuromodec 2024 NY Neuromodulation Conference! 🌙✨ Just discovered a new FDA-cleared wearable for insomnia treatment - a medication-free solution for better sleep. Check out Neurovalens for more details and join the discussion on innovative wearables in night time health! For further insights, click here: https://rdcu.be/dPRBo. #Neuromodec2024 #WearableTech #InsomniaTreatment #NightHealth 🌃💤
-
A great few days at the 2024 NYC Neuromodulation Conference presenting the Electrical Vestibular Nerve Stimulation (VeNS) for the Treatment of Chronic Insomnia. A Randomized, Double-Blind Sham-Controlled Trial. Come and talk to us in the main exhibit hall at poster A84 to learn more about Modius Sleep. Ulster University #nycn2024 #Neuromodulation2024 #ModiusSleep #HealthTech #InsomniaTreatment #neurostimulation #healthcareinnovation
-
+1
-
This week, the Neurovalens team is presenting our research at NYC Neuromodulation Conference 2024. We're looking forward to sharing and gaining insights into the most important advances in neurotechnology and neuromodulation, and connecting with other scientists, technologists and clinicians from around the world. We will be presenting research posters and delivering a presentation about Modius Sleep, our FDA-cleared, non-drug, non-invasive neurostimulation headset indicated to treat the symptoms of Chronic Insomnia. Visit us at poster A84 in the main exhibit hall to try Modius Sleep and find out more. Neuromodec Jason McKeown Sinead Watson Kate Willis #nycn2024 #Neuromodulation2024 #ModiusSleep #HealthTech #InsomniaTreatment #neurostimulation #healthcareinnovation #neurovalens
-
Are you getting enough sleep? The CDC indicates that sleep patterns vary widely across the United States. While Minnesota and Vermont report the highest amounts of sleep, Hawaii struggles the most, with 45.6% of adults getting less than seven hours of sleep each night. Discover how our FDA-cleared Modius Sleep device can help you achieve better rest and improve your overall health. Learn more: https://ow.ly/keF250SIYN3 #SleepHealth #ModiusSleep #HealthTech #InsomniaTreatment Reference: https://ow.ly/p17u50SIYN4